Fortress Biotech Inc. | Ownership
Companies that own Fortress Biotech Inc.
BlackRock Fund Advisors
1,738,425
3.2%
92,560
0%
06/30/2018
The Vanguard Group, Inc.
1,155,069
2.13%
8,232
0%
06/30/2018
SSgA Funds Management, Inc.
511,159
0.94%
10,891
0%
06/30/2018
Granite Point Capital Management LP
480,000
0.88%
480,000
0.38%
06/30/2018
Northern Trust Investments, Inc.
380,293
0.7%
-26,843
0%
06/30/2018
Geode Capital Management LLC
323,288
0.6%
21,077
0%
06/30/2018
American Investors Advisors, Inc.
264,800
0.49%
0
8.51%
12/31/2017
Highbridge Capital Management LLC
202,383
0.37%
202,383
0.01%
06/30/2018
State Teachers Retirement System of Ohio
202,100
0.37%
75,900
0%
06/30/2018
DWS Investment GmbH
160,722
0.3%
51,838
0%
06/30/2018
Address |
2 Gansevoort Street New York New York 10014 United States
|
Employees
|
- |
Website |
http://www.fortressbiotech.com |
Updated |
07/08/2019 |
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. |